Polygenic Risk Score Series | Explore Future Uses for Polygenic Risk Scores

May 8, 2019

In the final chapter of the PRS series, learn more about future uses for polygenic risk scores, from stratifying populations and targeting high-risk individuals to early intervention and preventative medicine. Industry experts from the University of Queensland, Genome Analytics Japan, King’s College, and the Bio-X Institute at Shanghai Jiao Tong University share their visions for the future.<br>

View related article: Polygenic Risk Scores Could Become Useful Tools in the Physician's Toolbox

<a href="/content/illumina-marketing/en/science/customer-stories/icommunity-customer-interviews-case-studies/queensland-interview-prs-gsa.html">Read Article</a><br>

Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc<br>

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.<br>

*Data calculations on file. Illumina, Inc., 2015.<br>

View customer spotlight videos


View Illumina webinars


View Illumina product videos


View Illumina support videos


Share this article on